Polissonin (Polysponinum)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsppills
Composition:

For one tablet:

Active ingredient:

Polissonin

(Dioscorei Nippon rhizomes with roots extract)

extract dry with the content of the amount of furostanol

Aglycons in terms of diosgenin and completely dry

substance 1.0%

- 0.10 g

Excipients:

Milk sugar (lactose monohydrate)

- 0.017 g

Potato starch

- 0.013 g

Magnesium oxide

- 0.007 g

Calcium stearate

0.003 g

Weight of a tablet

- 0.14 g
Description:

Tablets are round, flat-cylindrical, with a bevel, from light brown to brown with lighter and darker patches.

Pharmacotherapeutic group:lipid-lowering agent of plant origin
ATX: & nbsp
  • Other lipid-lowering drugs
    • Pharmacodynamics:

    Reduces cholesterol, increases the phospholipids in the blood and lowers the cholesterol / phospholipid coefficient; lowers blood pressure.

    Indications:

    Hypercholesterolemia (mild and moderate).

    Atherosclerosis of cerebral vessels both in its initial stages (for prophylaxis) and in severe forms of the disease; atherosclerosis of the heart vessels and the combination of atherosclerosis with hypertensive disease (as part of complex therapy).

    Contraindications:

    Hypersensitivity to the drug components, lactase deficiency, lactose intolerance,glucose-galactose malabsorption, age to 18 years.

    Carefully:

    Arterial hypotension.

    Pregnancy and lactation:

    It is not recommended for use in pregnancy and during breastfeeding because of the lack of specific safety data for this category of patients.

    Dosing and Administration:

    Inside.

    1-2 tablets 2-3 times a day after meals.

    Treatment is carried out in cycles of 20-30 days with 7-10-day intervals. The course of treatment is 3-4 months.

    Side effects:

    Possible allergic reactions (skin itching), decreased appetite, increased sweating.

    If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, tell your doctor.

    Overdose:

    In case of an overdose, dose-dependent side effects may be increased.

    Interaction:

    Not installed.

    Effect on the ability to drive transp. cf. and fur:

    The use of the drug does not affect the performance of potentially hazardous activities requiring special attention and quick reactions (vehicle management, working with moving mechanisms, dispatcher and operator work, etc.).

    Form release / dosage:Tablets, 100 mg.
    Packaging:

    10 tablets per contour cell pack.

    2, 3 or 5 contour mesh packages together with instructions for use in a pack of cardboard.

    Storage conditions:

    In a dry, the dark place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-000793
    Date of registration:03.10.2011
    Date of cancellation:2016-10-03
    The owner of the registration certificate:VIFITEH, CJSC VIFITEH, CJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspVIFITEH, CJSCVIFITEH, CJSC
    Information update date: & nbsp22.03.2016
    Illustrated instructions
      Instructions
      Up